尿中バイオマーカーを用いたCOVID-19のリスク層別化

基本情報

NCT ID

NCT04681040

ステータス

実施中（募集終了）

試験のフェーズ

-

試験タイプ

観察

目標被験者数

964

治験依頼者名

National Center for Global Health and Medicine, Japan

概要

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in infected patients, it produces symptoms which range from completely asymptomatic to those expressing severe illness. Early recognition of those developing severe manifestations allows for rapid and appropriate intervention, including admission to intensive care unit and intensive care therapy, such as mechanical ventilation. A current problem is that only limited data exist predicting the clinical course of COVID-19. This study will determine whether non-invasive urinalysis is useful in assessing and predicting the severity or clinical course of patients with COVID-19.

対象疾患

依頼者（Sponsor）

実施施設 (3)